FTC Seeks Dismissal of Watson, Allergan Claims on Limited Scope of Authority

The FTC wants a federal court to dismiss a complaint from Watson and Allergan over the agency’s authority to pursue federal lawsuits alleging prior misconduct.
Source: Drug Industry Daily